Thirty-year smoking duration-based criteria could reduce eligibility gaps for all races relative to whites, while improving ...
The FDA today approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of progressive pulmonary fibrosis (PPF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback